Search for: "AstraZeneca Pharmaceuticals, LP" Results 41 - 60 of 97
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2016, 8:26 am by Tom Lamb
These medications are available by prescription and over-the-counter (OTC) from various pharmaceutical companies, for example: PRILOSEC (omeprazole magnesium) | prescription drug | AstraZeneca LPPRILOSEC OTC (omeprazole magnesium) | over-the-counter | Procter & Gamble Manufacturing Co.PREVACID (lansoprazole) | prescription drug | Takeda Pharmaceuticals America, Inc.PREVACID 24 HR (lansoprazole) | over-the-counter | Novartis Consumer Health, Inc.NEXIUM (esomeprazole… [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
25 May 2012, 11:32 am by Robert Vrana
Judge Stark cited the Federal Circuit’s recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
11 Dec 2011, 9:00 pm by Stephanie Figueroa
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]
29 Aug 2016, 12:30 pm by Tom Lamb
For use as an example, here is the relevant part of an August 17, 2016 FDA Supplemental Approval letter to AstraZeneca Pharmaceuticals LP for Farxiga: Please refer to your supplemental New Drug Application (sNDA) dated and received July 28 2016, submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (FDCA) for Farxiga (dapagliflozin) tablets. [read post]
8 Feb 2009, 9:35 pm
AstraZeneca Pharmaceuticals LP, No. 6:07-cv-15733-Orl-22DAB, slip op. [read post]
27 Feb 2015, 5:02 am by Mary Jane Wilmoth
AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act. [read post]
3 Nov 2010, 5:56 am by The Docket Navigator
Astrazeneca Pharmaceuticals LP, et. al., 2-08-cv-04786 (PAED October 20, 2010, Memorandum and/or Opinion) (Yohn, J.) [read post]
3 Oct 2010, 8:57 pm by Patent Docs
Astrazeneca Pharmaceuticals LP... [read post]
28 Aug 2009, 8:11 am
Hewlett-Packard Company, AstraZeneca Pharmaceuticals LP, Dow Chemical Company, Advanced Micro Devices, Inc., Dreamworks Animation SKG, et al. [read post]
9 Jul 2012, 7:41 pm by FDABlog HPM
Karst –  In a decision that, unless appealed, marks the end of AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) battle with FDA over the approval of generic versions of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets, the U.S. [read post]
23 Sep 2009, 10:02 pm
AstraZeneca Pharmaceuticals LP, No. 08-1056 (1st Cir. [read post]
15 Feb 2011, 4:06 am by Andrew Frisch
AstraZeneca LP, 605 F.Supp.2d 669, 678-79 (W.D.Pa.2009) (discussing why the “professional paradigm” places the physician as the relevant decision maker in the health services industry), aff’d on other grounds, 372 Fed. [read post]